Dec 17, 2024 8:50am EST Sonnet BioTherapeutics Reports Fiscal Year 2024 Financial Results and Provides Corporate Update
Dec 9, 2024 3:42pm EST Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
